Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension
TRPV4 dominant mutations cause neuropathy. Here, the authors show that TRPV4 binds and interacts with RhoA, modulating the actin cytoskeleton. Neuropathy-causing mutations of TRPV4 disrupt this complex, leading to RhoA activation and impairment of neurite extension in cultured cells and flies.
Guardado en:
Autores principales: | Brett A. McCray, Erika Diehl, Jeremy M. Sullivan, William H. Aisenberg, Nicholas W. Zaccor, Alexander R. Lau, Dominick J. Rich, Benedikt Goretzki, Ute A. Hellmich, Thomas E. Lloyd, Charlotte J. Sumner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c12c32fb25af4c0fbec8907050b017a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRPV4 Mechanotransduction in Fibrosis
por: Ravi K. Adapala, et al.
Publicado: (2021) -
ProBDNF collapses neurite outgrowth of primary neurons by activating RhoA.
por: Ying Sun, et al.
Publicado: (2012) -
TRPV4 disrupts mitochondrial transport and causes axonal degeneration via a CaMKII-dependent elevation of intracellular Ca2+
por: Brian M. Woolums, et al.
Publicado: (2020) -
Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4
por: Hsueh-Hui Yang, et al.
Publicado: (2021) -
Identification of TRPV4 as a novel target in invasiveness of colorectal cancer
por: Peng Zhang, et al.
Publicado: (2021)